UNSPSC 51183900: Antidiabetic and hyperglycemic peroxisome proliferator-activated receptors

This classification denotes substances that constitute nuclear receptor proteins, substances which regulate gene expression, substances called peroxisome proliferator-activated receptors, that lower blood glucose levels, thus the term ANTIDIABETIC AND HYPERGLYCEMIC PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS.

UNSPSC 51183900 Antidiabetic and hyperglycemic peroxisome proliferator-activated receptors, a Class code, covers pharmaceutical agents used to manage blood glucose levels and metabolic disorders in patients with diabetes and related conditions. State and local procurement activity under this code includes purchase of specific drug formulations and therapeutic agents within the PPAR drug class, typically acquired by health departments, public hospital systems, and Medicaid agencies to stock formularies, support outpatient clinics, and fulfill prescription benefits for eligible populations. The issuing bodies are primarily state health agencies, county public health departments, and municipal hospital authorities responsible for pharmaceutical procurement and patient care delivery.

The source provided contains no recent state and local solicitation records under this code. Without posted RFP, RFQ, IFB, or ITB notices in the <most-recent-state-local-contract-opportunities> block, geographic concentration and current market activity cannot be characterized. Firms monitoring this code should establish alerts with state Medicaid procurement offices and public hospital cooperative purchasing groups to capture opportunities when they emerge, as pharmaceutical acquisitions often flow through standing contracts and formulary updates rather than frequent open solicitations.